Onchilles Pharma
Latest round
- Series A
Last raised
- Nov 2025
Total raised
- $32M
Investors
- 6
About Onchilles Pharma
Based in California, US, and founded in 2017, Onchilles Pharma, Inc. operates as a biotechnology company that develops first-in-class drug candidates. The company was co-founded by Court R. The company's line of product includes ELANE (Elastase, Neutrophil Expressed) is a new treatment paradigm that helps to kills cancer cells regardless of genetic mutation or anatomical origin. Onchilles Pharma plans to advance the first drug candidate through preclinical proof-of-concept and interrogate the novel pathway for further pipeline development.
Who invested in Onchilles Pharma
6 investors across 2 rounds
See all investors in Onchilles Pharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Onchilles Pharma
Who invested in Onchilles Pharma?
Onchilles Pharma has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Onchilles Pharma raised?
Onchilles Pharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Onchilles Pharma last raise money?
Onchilles Pharma's most recent round on record is a Series A, in Nov 2025.
What does Onchilles Pharma do?
Based in California, US, and founded in 2017, Onchilles Pharma, Inc.
Where is Onchilles Pharma headquartered?
Onchilles Pharma is headquartered in San Diego, US.
Which VCs invest in companies like Onchilles Pharma?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Onchilles Pharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Onchilles Pharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.